UPDATE : Monday, September 16, 2019
T&R Biofab gets Philippine nod for medical device
T&R Biofab said Wednesday that it has obtained sales approval from the Phil...
by Lee Han-soo  |  2019-07-31 15:44
Lunit's AI-based software assisting breast cancer diagnosis wins regulatory nod
Lunit said that it has received approval for "Lunit INSIGHT for Mammography...
by Lee Han-soo  |  2019-07-31 14:31
Novartis fails to expand heart failure drug Entresto’s indication
Novartis said its phase-3 Paragon-HF trial on heart failure treatment Entre...
by Kim Yun-mi  |  2019-07-31 14:26
Journal of Stroke tops citation index among domestic journals
Journal of Stroke, a journal by the Korean Stroke Society, ranked No. 1 in ...
by Song Soo-youn  |  2019-07-31 11:38
Hanmi marks ₩270.4 billion in Q2 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 270.4 billion w...
by Lee Han-soo  |  2019-07-30 17:26
Allergan recalls breast implants
Allergan said it has issued a worldwide recall of "Biocell" textured breast...
by Lee Han-soo  |  2019-07-30 16:23
One in 45 Koreans prescribed with diet pills
One in 45 Koreans was prescribed with an appetite suppressant for obesity t...
by Lee Hye-seon  |  2019-07-30 15:44
Kolmar Korea boosts beauty, health biz through acquisitions
Kolmar Korea Holdings, having units in cosmetics, pharmaceuticals, and heal...
by Park Gi-taek  |  2019-07-30 14:43
Diabetic women with heart failure have higher risk of recurrence, death than men
A research team at Seoul National University Boramae Hospital has discovere...
by Lee Han-soo  |  2019-07-30 14:42
Rare Fabry disease depicted in K-dramas
Recent SBS drama “Doctor John” and MBC’s “Partners for Justice Season 2” us...
by Lee Hye-seon  |  2019-07-30 12:40
H+ Yangji Hospital makes accord with Mongolian hospital
H+ Yangji Hospital said that it has signed a medical agreement with Mongoli...
by Lee Han-soo  |  2019-07-30 12:38
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval
GC said that CANBridge Pharmaceuticals, its Chinese partner, has applied fo...
by Lee Han-soo  |  2019-07-30 10:49
‘Sound amplifier as effective as hearing aid in moderate hearing loss’
A study has shown that moderate hearing loss patients can use a relatively ...
by Lee Han-soo  |  2019-07-30 10:48
‘FDA likely to OK 11 blockbuster candidates in August’
The U.S. Food and Drug Administration (FDA) will likely approve 11 innovati...
by Kim Yun-mi  |  2019-07-29 16:55
Top-30 makers produce more than half of drugs
Drug output by 30 largest pharmaceutical companies accounted for 54 percent...
by Lee Hye-seon  |  2019-07-29 16:38
Researchers develop next-generation immunotherapy
Researchers at CHA Bundang Medical Center have developed a new treatment th...
by Lee Han-soo  |  2019-07-29 16:37
CNUHH introduces Korea’s 1st 4K-3D laparoscopic surgical system
Chonnam National University Hwasun Hospital (CNUHH) has become the first Ko...
by Lee Han-soo  |  2019-07-29 14:23
‘Premature short babies more vulnerable to chronic lung disease’
Researchers at Seoul National University Bundang Hospital have discovered t...
by Lee Han-soo  |  2019-07-29 12:04
Takeda’s Zejula poised to change local ovarian cancer treatment market
Takeda’s Zejula (ingredient: niraparib) became eligible for an insurance be...
by Kim Yun-mi  |  2019-07-29 12:04
Pfizer's Besponsa, Takeda's Zejula likely to get insurance coverage
Pfizer's Besponsa, a B-cell lymphoblastic leukemia treatment, and Taked...
by Lee Han-soo  |  2019-07-26 17:57
Back to Top